CELL REPROGRAM 润色咨询

Cellular Reprogramming

出版年份:2010 年文章数:497 投稿命中率: 开通期刊会员,数据随心看

出版周期:Bimonthly 自引率:8.3% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

投稿信息

投稿信息
审稿费用
暂无数据
版面费用
暂无数据
中国人发表比例
2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%)
自引率
8.3 %
年文章数
497
期刊官网
点击查看 (点击次数:5051)
点击查看 (点击次数:3041次)
作者需知
点击查看 (点击次数:208次)
期刊简介
稿件收录要求

Cellular Reprogramming is the premier journal dedicated to providing new insights on the etiology, development, and potential treatment of various diseases through reprogramming cellular mechanisms. The Journal delivers information on cutting-edge techniques and the latest high-quality research and discoveries that are transforming biomedical research.

Cellular Reprogramming coverage includes:

  • Somatic cell nuclear transfer and reprogramming in early embryos
  • Embryonic stem cells
  • Nuclear transfer stem cells (stem cells derived from nuclear transfer embryos)
  • Generation of induced pluripotent stem (iPS) cells and/or potential for cell-based therapies
  • Epigenetics
  • Adult stem cells and pluripotency

Cellular Reprogramming is under the editorial leadership of Editor-in-Chief Professor Sir Ian Wilmut, OBE FRS FRSE, MRC Centre for Regenerative Medicine, Scottish Centre for Regenerative Medicine, University of Edinburgh; Deputy Editor Jane Taylor, PhD, MRC Centre for Regenerative Medicine, Scottish Centre for Regenerative Medicine, University of Edinburgh; and other leading investigators. View the entire editorial board.

Audience: Cell biologists, embryologists, developmental biologists, genetic engineers, cloning scientists, stem cell researchers, and tissue engineers, among others.

Indexed/Abstracted in:

MEDLINE; PubMed; PubMed Central; Science Citation Index Expanded; BIOSIS Previews; Biotechnology Citation Index®; Biological Abstracts; EMBASE/Excerpta Medica; EMBiology; Scopus; AGRICOLA; Chemical Abstracts;ProQuest databases; CAB Abstracts; Global Health